5-HT2A receptor agonists (Onsero)

N/A

Report date: 2025/01/26 19:03:03
NME

Base Information

Drug Name5-HT2A receptor agonists (Onsero)
Drug Alias Name5-HT2A receptor agonists (UNC School of Medicine/University of California San Francisco/Stanford University School of Medicine/Yale university/Duke University Medical Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUNC School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesOnsero Therapeutics Inc
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A